Candel Therapeutics, Inc.(NASDAQ:CADL) 
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of cancer immunotherapy drugs. The company offers Gene Mediated Cytotoxic Immunotherapy technology-based drugs that are designed to work with radiation, chemotherapy, and surgery t...
Website: http://www.candeltx.com
Founded: 1999
CEO: Paul Peter Tak
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.09
H 5.19
L 4.67
C 4.82
V 1,218,584
10EMA 4.82
20EMA 4.82
60EMA 4.82
120EMA 4.82
250EMA 4.82